What we measure

The 2017 Access to Vaccines Index evaluates how 8 major vaccine companies are improving access to preventive vaccines for 69 priority diseases – including HIV/AIDS, Ebola and Zika – in 107 high-need countries. Find out more about the scope of the Index research.


Back to top |